Cardiovascular and hemodynamic parameters in women following prolonged CGRP inhibition using LBR-101, a monoclonal antibody against CGRP
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cardiovascular and hemodynamic parameters in women following prolonged CGRP inhibition using LBR-101, a monoclonal antibody against CGRP
Authors
Keywords
-
Journal
CEPHALALGIA
Volume 34, Issue 12, Pages 968-976
Publisher
SAGE Publications
Online
2014-03-25
DOI
10.1177/0333102414527646
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- BMS-927711 for the acute treatment of migraine: A double-blind, randomized, placebo controlled, dose-ranging trial
- (2013) Ronald Marcus et al. CEPHALALGIA
- Calcitonin Gene-Related Peptide (CGRP) and Migraine Current Understanding and State of Development
- (2013) Marcelo E. Bigal et al. HEADACHE
- A Randomized, Placebo-Controlled Study of the Effects of Telcagepant on Exercise Time in Patients With Stable Angina
- (2012) B R Chaitman et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Emerging Target-Based Paradigms to Prevent and Treat Migraine
- (2012) S D Silberstein CLINICAL PHARMACOLOGY & THERAPEUTICS
- Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine
- (2011) David J Hewitt et al. CEPHALALGIA
- New Agents for Acute Treatment of Migraine: CGRP Receptor Antagonists, iNOS Inhibitors
- (2011) Jan Hoffmann et al. Current Treatment Options in Neurology
- Electrocardiographic assessment for therapeutic proteins—scientific discussion
- (2010) Ignacio Rodriguez et al. AMERICAN HEART JOURNAL
- The potent calcitonin gene-related peptide receptor antagonist, telcagepant, does not affect nitroglycerin-induced vasodilation in healthy men
- (2010) Bart J. Van der Schueren et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura
- (2010) Jakob Møller Hansen et al. CEPHALALGIA
- Effect of Calcitonin Gene-Related Peptide Receptor Antagonism on the Systemic Blood Pressure Responses to Mechanistically Diverse Vasomodulators in Conscious Rats
- (2010) Joseph J Lynch et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Pharmacological Properties of MK-3207, a Potent and Orally Active Calcitonin Gene-Related Peptide Receptor Antagonist
- (2010) C. A. Salvatore et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Characterization of the Calcitonin Gene-Related Peptide Receptor Antagonist Telcagepant (MK-0974) in Human Isolated Coronary Arteries
- (2010) K. Y. Chan et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- CGRP and its receptors provide new insights into migraine pathophysiology
- (2010) Tony W. Ho et al. Nature Reviews Neurology
- Calcitonin gene-related peptide receptor antagonists and triptans: A tale of two treatments
- (2010) P. J. Goadsby NEUROLOGY
- Effects of the prototype serotonin 5-HT1B/1D receptor agonist sumatriptan and the calcitonin gene-related peptide (CGRP) receptor antagonist CGRP8–37 on myocardial reactive hyperemic response in conscious dogs
- (2009) Joseph J. Lynch et al. EUROPEAN JOURNAL OF PHARMACOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started